Prostatitis Clinical Trials 2023

Prostatitis Clinical Trials 2023

Prostatitis research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in prostatitis clinical trials today.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to prostatitis

What are the top hospitals conducting prostatitis research?

While prostatitis, a condition characterized by inflammation of the prostate gland, may not be as widely known as other urological conditions, top hospitals are diligently working to advance research and treatment options. The Cleveland Clinic Foundation in Cleveland has been making strides since recording their first prostatitis trial in 2006. Currently, they have two active trials dedicated to exploring potential solutions for this complex condition. In Albany, New york, Albany Medical Center is also contributing to the field with one ongoing prostatitis trial. However, it's worth noting that the University at Buffalo stands out on this list with two separate institutions located in the same city actively involved in groundbreaking studies related to prostatitis.

The University at Buffalo has emerged as a hub for cutting-edge research into this challenging medical issue. Both its main institution and clinical site are each conducting an active prostatitis trial while having recorded their first-ever trials just recently in 2022. This concentrated effort signifies a dedication to understanding and addressing the needs of patients who suffer from this inflammatory disorder.

Notably joining these esteemed facilities is Huntsman Cancer Institute at the University of Utah situated amidst picturesque Salt Lake City—a location renowned for its breathtaking scenery but also home to groundbreaking medical advancements. With an ongoing clinical trial focused on prostatitis treatment along with their initial study commencing only last year (in 2022), Huntsman Cancer Institute demonstrates how comprehensive medical care extends beyond cancer alone.

These remarkable hospitals represent beacons of hope for individuals living with prostatitis worldwide. Their collective efforts demonstrate a commitment towards unraveling the complexities surrounding this condition and providing improved outcomes and quality of life for those affected by it.

Which are the best cities for prostatitis clinical trials?

When it comes to prostatitis clinical trials, several cities are leading the way in research and development. Cleveland, Ohio; Buffalo, New york; Salt Lake City, Utah; Los Angeles, California; and Albany, New York each have active trials dedicated to studying different treatments for this condition. These trials focus on interventions like fSWT (Focused Shockwave Therapy), Minimal Contact-Cognitive Behavior Therapy, Q-Urol treatment, NSAIDs (Nonsteroidal Anti-Inflammatory Drugs), among others. With ongoing studies in these locations, individuals with prostatitis have access to cutting-edge research that aims to improve their diagnosis and treatment options.

Which are the top treatments for prostatitis being explored in clinical trials?

Prostatitis, a condition that affects many men worldwide, is undergoing exciting developments in clinical trials. One of the top treatments being explored is Minimal Contact-Cognitive Behavior Therapy (MC-CBT). This innovative therapy has garnered attention with 1 active trial dedicated solely to prostatitis and marks its debut on the research scene in 2022. The focus on MC-CBT highlights a growing understanding of the importance of psychological interventions in managing this challenging condition. With ongoing investigations into MC-CBT, there is hope for improved outcomes and better quality of life for individuals affected by prostatitis.

What are the most recent clinical trials for prostatitis?

Recent clinical trials for prostatitis have explored various treatment options to address this challenging condition. One study focused on the use of NSAIDs in the management of prostatitis, aiming to alleviate symptoms and improve patients' quality of life. Another trial investigated the efficacy and safety of Q-Urol as a potential intervention for prostatitis, offering hope for improved outcomes. These recent studies provide valuable insights into novel approaches that may benefit individuals suffering from prostatitis, fostering optimism within the medical community about future advancements in treating this debilitating condition.

What prostatitis clinical trials were recently completed?

Northwestern University recently completed a clinical trial in August 2017 investigating the potential of Cromolyn Sodium as a treatment for prostatitis. This study marks an important step towards understanding and treating this challenging condition.